Cargando…
Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
OBJECTIVE: To evaluate whether the efficacy and safety of menatetrenone for the treatment of osteoporosis is noninferior to alfacalcidol in Chinese postmenopausal women. METHOD: This multicenter, randomized, double-blinded, double-dummy, noninferiority, positive drug-controlled clinical trial was co...
Autores principales: | Jiang, Yan, Zhang, Zhen-Lin, Zhang, Zhong-Lan, Zhu, Han-Min, Wu, Yi-Yong, Cheng, Qun, Wu, Feng-Li, Xing, Xiao-Ping, Liu, Jian-Li, Yu, Wei, Meng, Xun-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890406/ https://www.ncbi.nlm.nih.gov/pubmed/24426779 http://dx.doi.org/10.2147/CIA.S54107 |
Ejemplares similares
-
Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial
por: Liang, Hanting, et al.
Publicado: (2022) -
Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study
por: Li, Nan, et al.
Publicado: (2018) -
Efficacy and Safety of Qinpi Tongfeng Formula in the Treatment of Acute Gouty Arthritis: A Double-Blind, Double-Dummy, Multicenter, Randomized Controlled Trial
por: Fan, Yihua, et al.
Publicado: (2022) -
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks
por: Chen, Xiao-Fan, et al.
Publicado: (2021) -
A double-blind, double-dummy, randomized controlled, multicenter trial of (99)Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis
por: Fu, Qiong, et al.
Publicado: (2021)